Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1.
about
Improving Cell Engraftment in Cardiac Stem Cell TherapyAngiomyogenesis for myocardial repair.Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium.Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.The road ahead: working towards effective clinical translation of myocardial gene therapies.Transmurally differentiated measurement of ATP hydrolysis rates in the in vivo porcine hearts.Genesis of myocardial repair with cardiac progenitor cells and tissue engineeringNonviral vector gene modification of stem cells for myocardial repair.Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation.Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heartNon-viral gene therapy for myocardial engineering.Construction and characterization of E1- and E3-deleted adenovirus vectors expressing two antigens from two separate expression cassettes.Skeletal myoblasts for cardiac repair.Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema.Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction.Co-delivery of vascular endothelial growth factor and angiopoietin-1 using injectable microsphere/hydrogel hybrid systems for therapeutic angiogenesis.Sequential, timely and controlled expression of hVEGF165 and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo.Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction.Nanoparticles combined with growth factors: recent progress and applications
P2860
Q26771255-D6B81323-2C77-4E9D-9CD8-2C8E8AC3866DQ30480151-DC38F62E-62C2-4DDF-9013-846775038F10Q30486444-5AEEC1A8-7BD8-4283-9A5E-B1936F9B163AQ30575719-51DDFFEC-4E46-4A07-8EB1-6AEC8F5CAE6AQ33705144-45C4B684-7B4F-454B-A66F-C30634C09753Q36803252-54EB857D-E30B-475F-9137-416257C0A602Q36982525-DC5A46D0-B0F5-4689-B065-C3021A5A8C93Q36994178-DE0CE40E-CFA7-447E-805F-147241E3ECDAQ37162061-851BD1B4-4221-451A-B304-904FDA290B84Q37216646-A965D0F2-1B36-4146-AFDD-822D59A342D4Q37671758-DC2C0552-79F2-4649-A854-23B933C061D6Q37718956-7E4B404D-AD3C-4489-881B-C5D15118A171Q37810057-356E960B-077E-40F6-952C-3C602A8F98CEQ38990050-FAE5E298-EAC2-4674-8292-962940D28DFFQ42464386-921CFEC5-A29B-446D-9396-2C4F3EC6EB84Q44003626-F5EAFD38-8C6D-4CD9-A01F-9554A0B0B796Q45885896-DB951C3B-9DAD-495B-9F91-F129E4BED679Q50282696-C8D46B72-A221-4FCE-97F6-DF29B6F0EC83Q57377197-300C921D-4AF9-4DB9-A2B6-A9444511BD2A
P2860
Improved angiogenic response in pig heart following ischaemic injury using human skeletal myoblast simultaneously expressing VEGF165 and angiopoietin-1.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Improved angiogenic response i ...... ng VEGF165 and angiopoietin-1.
@en
Improved angiogenic response i ...... ng VEGF165 and angiopoietin-1.
@nl
type
label
Improved angiogenic response i ...... ng VEGF165 and angiopoietin-1.
@en
Improved angiogenic response i ...... ng VEGF165 and angiopoietin-1.
@nl
prefLabel
Improved angiogenic response i ...... ng VEGF165 and angiopoietin-1.
@en
Improved angiogenic response i ...... ng VEGF165 and angiopoietin-1.
@nl
P2093
P2860
P1476
Improved angiogenic response i ...... ing VEGF165 and angiopoietin-1
@en
P2093
Eugene K W Sim
Husnain Kh Haider
Peter K Law
Shujia Jiang
P2860
P356
10.1016/J.EJHEART.2006.04.008
P577
2006-07-07T00:00:00Z